FDA (Tag Archives)
Subscribe to PricePlow's Newsletter and FDA Alerts
Lief Labs: Supplement Manufacturing 101 with Meg Ligot | Episode #101
https://blog.priceplow.com/podcast/lief-labs-supplement-manufacturing-101
Over the years, PricePlow has continually become more interested in supplement manufacturing, as it is the cornerstone basis of the entire industry. Good manufacturing quality and testing leads to safe, high-quality products for end consumer.
In Episode #068, we interviewed Matt Karich of Soul Performance Nutrition, who took us through his exhaustive […]
Continue Reading →
Dan Fabricant (NPA): Why You Need to Show Up in Washington DC | Episode #100
https://blog.priceplow.com/podcast/dan-fabricant-npa-2023-washington-dc
For Episode 100 of the PricePlow Podcast, Ben and Mike flew to Washington D.C. for the Natural Products Association’s annual DC Fly-In Day on June 7, 2023. Fly-in days, also known as “lobby days”, bring individuals together to advocate with legislators and other officials on behalf of their shared interests.
So this was […]
Continue Reading →
Melatonin and CBD Under Fire? Meet Pieter Cohen, the Grim Reaper of ‘Gray Area’ Ingredients
The Journal of the American Medicine Association (JAMA) recently published a study showing that the quality control on melatonin gummies in the United States may not be the best – unfortunately, only 12% of the products tested were FDA compliant.[1]
Reason being, the FDA generally allows a discrepancy of up to 10% between a product’s […]
Continue Reading →
Dr. Sibyl Swift & Lance Blundell: cbdMD Re-Educates the FDA on Hemp | Episode #089
https://blog.priceplow.com/podcast/sibyl-swift-lance-blundell-cbdmd-089
On March 27, 2023 we hosted a tremendous conversation with Dr. Sibyl Swift and Lance Blundell of cbdMD, a premier hemp-based health solution company that sells CBD — and even THC — based supplements. In Lance’s words, they are a “hemp-extracted cannabinoid company”.
Sibyl is cbdMD’s Chief Science Officer & VP of Regulatory Affairs[…]
Continue Reading →
FDA Announcement on CBD: We Need Help from Congress
On January 26th, 2023, the FDA made a major announcement regarding CBD (Cannabidiol), coming after years of deliberation, debate, and discussion. The gist of the message:
“We need help from Congress!”
View this post on InstagramFDA to Congress: We need more tools!
In a press release titled […]
Continue Reading →
The Top 5 Supplement Industry Trends from SupplySide West 2022
SupplySide West 2022 has come and gone, but this year’s annual trip to Las Vegas left a lasting impression. SupplySide West (SSW) is an annual industry trade show run by Informa Markets that gathers professionals across the supply chains of the dietary supplement ingredient and functional foods/beverages industries.
This trade show is best for catching […]
Continue Reading →
Myprotein “Whey Forward”: Animal-Free Protein Fermented from GMO Fungus by Perfect Day
Just when you thought Myprotein couldn’t possibly come out with any new types of protein — they’ve got everything from whey protein to bars and snacks to plant proteins, after all — they stun the industry with something completely different.
Today, we’re going to talk in depth about their new animal-free whey protein alternative: Myprotein […]
Continue Reading →
The NPA is Fighting Dick Durbin’s 2022 Supplement Bill (S.4090) | Episode #067
https://blog.priceplow.com/podcast/npa-vs-dick-durbin-s4090
On April 26, Senators Dick Durbin (IL) and Mike Braun (IN) proposed a bill titled Dietary Supplement Listing Act of 2022,[1,2] which would have serious ramifications on the way business and commerce is done in the dietary supplement industry.
We invited a powerhouse team of industry veterans and experts to discuss what this […]
Continue Reading →
Season 2 Kickoff – Ben and Mike | PPP #051
Welcome to Season 2 of the PricePlow Podcast!
Mike and Ben get together for a long-overdue podcast to catch up on 2021 and to kick off Season 2 of the PricePlow Podcast! We talk about several topics, including:
The economy
Hiring help at PricePlow
Product Launches of 2021
What’s coming in Q4-2021 and 2022
Immunity, […]
Continue Reading →